open access

Vol 8, No 2 (2023)
Editorial
Published online: 2023-04-18
Get Citation

Candida auris as a significant emerging human fungal pathogen

Michal Pruc12, Maciej J. Krajsman13, Stepan Feduniw4, Piotr Szczepanski3, Julia Holzer5, Anna Jaroszewska6, Lukasz Szarpak578
·
Disaster Emerg Med J 2023;8(2):61-63.
Affiliations
  1. Research Unit, Polish Society of Disaster Medicine, Warsaw, Poland
  2. Research Unit, International Academy of Ecology and Medicine, Kyiv, Ukraine
  3. Department of Medical Informatics and Telemedicine, Medical University of Warsaw, Poland
  4. Department of Gynecology, University Hospital Zurich, Frauenklinikstrasse, Zurich, Switzerland
  5. Institute of Outcomes Research, Maria Sklodowska-Curie Medical Academy, Warsaw, Poland
  6. Research Unit, NZOZ Salus s.c, Chorzele, Poland
  7. Henry JN Taub Department of Emergency Medicine, Baylor College of Medicine, Houston, USA
  8. Research Unit, Maria Sklodowska-Curie Bialystok Oncology Center, Bialystok, Poland

open access

Vol 8, No 2 (2023)
EDITORIAL
Published online: 2023-04-18

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Candida auris as a significant emerging human fungal pathogen

Journal

Disaster and Emergency Medicine Journal

Issue

Vol 8, No 2 (2023)

Article type

Editorial

Pages

61-63

Published online

2023-04-18

Page views

1246

Article views/downloads

307

DOI

10.5603/DEMJ.a2023.0014

Bibliographic record

Disaster Emerg Med J 2023;8(2):61-63.

Authors

Michal Pruc
Maciej J. Krajsman
Stepan Feduniw
Piotr Szczepanski
Julia Holzer
Anna Jaroszewska
Lukasz Szarpak

References (15)
  1. Szarpak L, Chirico F, Pruc M, et al. Mucormycosis—A serious threat in the COVID-19 pandemic? Journal of Infection. 2021; 83(2): 237–279.
  2. Ruetzler K, Szarpak L, Filipiak K, et al. The COVID-19 pandemic — a view of the current state of the problem. Disaster and Emergency Medicine Journal. 2020.
  3. Smereka J, Szarpak L, Filipiak K. Modern medicine in COVID-19 era. Disaster and Emergency Medicine Journal. 2020.
  4. Chowdhary A, Sharma C, Meis J. Candida auris: A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally. PLOS Pathogens. 2017; 13(5): e1006290.
  5. Magnasco L, Mikulska M, Giacobbe DR, et al. Spread of Carbapenem-Resistant Gram-Negatives and during the COVID-19 Pandemic in Critically Ill Patients: One Step Back in Antimicrobial Stewardship? Microorganisms. 2021; 9(1).
  6. Centers for Disease Control and Prevention. Increasing Threat of Spread of Antimicrobial-resistant Fungus in Healthcare Facilities, Centers for Disease Control and Prevention. CDC 2016. https://www cdc gov/media/releases/2023/p0320-cauris html (29 Mar 2023).
  7. Du H, Bing J, Hu T, et al. Candida auris: Epidemiology, biology, antifungal resistance, and virulence. PLOS Pathogens. 2020; 16(10): e1008921.
  8. Kathuria S, Singh P, Sharma C, et al. Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek 2, CLSI Broth Microdilution, and Etest Method. Journal of Clinical Microbiology. 2015; 53(6): 1823–1830.
  9. Chowdhary A, Sharma A. The lurking scourge of multidrug resistant Candida auris in times of COVID-19 pandemic. Journal of Global Antimicrobial Resistance. 2020; 22: 175–176.
  10. Kordalewska M, Lee A, Park S, et al. Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris. Antimicrobial Agents and Chemotherapy. 2018; 62(6).
  11. Centers for Disease Control and Prevention. Candida auris: Antifungal susceptibility testing and interpretation 2020. https://www.cdc.gov/fungal/candida-auris/c-auris-antifungal.html (29 Mar 2023).
  12. Centers for Disease Control and Prevention. Candida auris: A Drug-resistant Germ That Spreads in Healthcare Facilities 2018. https://www.cdc.gov/fungal/candida-auris/c-auris-drug-resistant.html (29 Mar 2023).
  13. Al-Rashdi A, Al-Maani A, Al-Wahaibi A, et al. Characteristics, Risk Factors, and Survival Analysis of Candida auris Cases: Results of One-Year National Surveillance Data from Oman. Journal of Fungi. 2021; 7(1): 31.
  14. Evrin T, Szarpak L, Pruc M. Self-testing as a method of reducing COVID-19 infections. Disaster and Emergency Medicine Journal. 2021; 6(2): 94–95.
  15. Szarpak L, Pruc M, Navolokina A, et al. Omicron variants of the SARS-COV-2: A potentially significant threat in a new wave of infections. Disaster and Emergency Medicine Journal. 2022; 7(3): 139–141.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl